SCHEMBL7250935

SCHEMBL7250935

NCc1ccc(CNCc2ccc(Cl)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.55
ALDH1A1 P00352 1/20 0.55
MAOB P27338 2/20 0.52
SMN1; SMN2 Q16637 1/20 0.50
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
TAAR1 Q96RJ0 2/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA4 P22748 1/20 0.46
CA9 Q16790 1/20 0.46
GAA P10253 1/20 0.46
TPSAB1 Q15661 2/20 0.45
PNMT P11086 1/20 0.45
ANPEP P15144 1/20 0.44
ERAP2 Q6P179 1/20 0.44
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL415949 0.88 CHRM2 (0.67) CHRM2ALDH1A1SMN1; SMN2CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL7695180 0.85 CHRM2 (0.64) CHRM2ALDH1A1SMN1; SMN2CYP2C9CYP2C19
SCHEMBL107396 0.85
SCHEMBL626104 0.85 PNMT (0.50) CHRM2ALDH1A1MAOBTAAR1TPSAB1
SCHEMBL11953353 0.84 CHRM2 (0.57) CHRM2ALDH1A1MAOBSMN1; SMN2CYP2C9
Hydrochloric Acid SCHEMBL9479829 0.83 CHRM2 (0.61) CHRM2ALDH1A1SMN1; SMN2CYP2C9CYP2C19
Ammonia Solution, Strong SCHEMBL9177329 0.83 MAOB (0.61) MAOBTAAR1PNMTHRH3
Hydrochloric Acid SCHEMBL927415 0.83 MAOB (0.65) MAOBTAAR1PNMTHRH3
Iodide SCHEMBL29120576 0.83 MAOB (0.61) MAOBTAAR1PNMTHRH3
Bromide SCHEMBL31513717 0.83 MAOB (0.61) MAOBTAAR1PNMTHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6512000-B1 Aminocarbonyl- substituted benzimidazole derivatives for the treatment of diseases in which inhibition of tryptase is of therapeutic such as for treating an inflammatory or allergic disease BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-01-28 US disclosed